<--- Back to Details
First PageDocument Content
Ribbon symbolism / Breast cancer / Organofluorides / Cancer organizations / Tyrosine kinase inhibitors / Metastatic breast cancer / Triple-negative breast cancer / Trastuzumab / Lapatinib / Medicine / Oncology / Chemistry
Date: 2015-01-16 18:57:59
Ribbon symbolism
Breast cancer
Organofluorides
Cancer organizations
Tyrosine kinase inhibitors
Metastatic breast cancer
Triple-negative breast cancer
Trastuzumab
Lapatinib
Medicine
Oncology
Chemistry

20150105_Adult_Interventional_Trials_UCSF.xls

Add to Reading List

Source URL: cancer.ucsf.edu

Download Document from Source Website

File Size: 255,71 KB

Share Document on Facebook

Similar Documents

Bioluminescent orthotopic PDX models of primary pancreatic cancer and residual/metastatic breast cancer to predict efficacy of standard of care and experimental treatments Benjamin G. 1 Cuiffo ,

DocID: 1uQqF - View Document

Jose Falcon Father, Co-Survivor and Veteran Tour de Pink Rider My name is Jose Falcon and I am the proud father and caregiver to my only daughter, Kayla Falcon. She was diagnosed with Stage 4 Metastatic breast cancer at

DocID: 1trwM - View Document

Medicine / Health / Clinical medicine / Ribbon symbolism / RTT / Breast cancer / Metastatic breast cancer / Oncology / Bone metastasis / Radiation therapy / Brain metastasis / Metastatic liver disease

· METASTATIC BREAST CANCER · Assessing Treatment Response in Metastatic Breast Cancer Shlomit Strulov Shachar, MD, and Hyman B. Muss, MD Abstract

DocID: 1rmV3 - View Document

Medicine / Clinical medicine / Transplantation medicine / Graft-versus-host disease / Hematopoietic stem cell transplantation / Breast cancer / Treatment of cancer / Chemotherapy / Metastatic breast cancer / Graft versus tumor effect / Cell therapy / Lumpectomy

Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer

DocID: 1riiF - View Document

Health / Medicine / Clinical medicine / Ribbon symbolism / RTT / Breast cancer / Metastatic breast cancer / CCL2 / Friedrich Miescher Institute for Biomedical Research / Metastasis / Tumor microenvironment / Angiogenesis

Media release, October 23, 2014 Stopping anti-CCL2 breast cancer treatment aggravates the disease Mohamed Bentires-Alj and his team at the Friedrich Miescher Institute for Biomedical Research (FMI) together with scienti

DocID: 1rf3r - View Document